Clinical Development & Late Stage Research

Janine Collins, MBBS, LLM, Senior Director, European Risk Management - February 18, 2014
Last week, more than 100 senior Late Phase pharmaceutical professionals and key opinion leaders representing Medical and Scientific Affairs, Health Economics and Outcomes Research, Safety and Risk Management, Regulatory, Market Access...
A UBC study assesses health-related quality of life of multiple myeloma patients
UBC - February 14, 2014
A study, designed and undertaken by medical and industry experts including Krista Payne and Noreen Lordan of UBC, assesses the health-related quality of life (HRQoL) of 154 patients with multiple myeloma (MM).  This cross-...
UBC - February 06, 2014
The convergence of payer and regulator evidence requirements warrants a strategic evidence generation plan and a mindful orchestration of peri and postapproval real-world studies.  Study designs resulting in a diverse array of...
UBC - January 31, 2014
Beginning tomorrow through Thursday, representatives from UBC will be participating in the Cambridge Healthtech Institute's Summit for Clinical Ops Executives (SCOPE). Members of the clinical trial community will convene in Miami for...
Mary James, Senior Manager, Patient and Physician Services - January 31, 2014
The challenges associated with conducting and managing today’s larger, multinational clinical trials have never been greater. There has been a dramatic increase in costs and trial complexity over the last several years resulting in...

Pages